GEBT Lot-to-Lot and Biological Variability - Trial NCT04772261
Access comprehensive clinical trial information for NCT04772261 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairn Diagnostics and is currently Completed. The study focuses on Gastroparesis. Target enrollment is 21 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairn Diagnostics
Timeline & Enrollment
N/A
Feb 05, 2021
Jan 10, 2022
Primary Outcome
Lot to Lot Variability,Lot to Lot Variability,Lot to Lot Variability,Biological Variability,Biological Variability
Summary
The purpose of this study is to collect information regarding lot-to-lot variability in
 13C-Spirulina test meal lets and within-subject biological variability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04772261
Non-Device Trial